


Retatrutide (5MG)
10 mg Lyophilized powder.
PLEASE READ OUR FAQ BEFORE YOU ORDER. CLICK HERE
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This product is intended for in vitro laboratory research use only. All Information on this website is for educational purposes only.
This product should only be handled by licensed, qualified professionals.
This product is not a food, drug, or supplement and may not be misbranded, misused or mislabled as a food, drug, or supplement.
Bodily Introduction of any kind into humans or animals is strictly forbidden by law.
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.
10 mg Lyophilized powder.
PLEASE READ OUR FAQ BEFORE YOU ORDER. CLICK HERE
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This product is intended for in vitro laboratory research use only. All Information on this website is for educational purposes only.
This product should only be handled by licensed, qualified professionals.
This product is not a food, drug, or supplement and may not be misbranded, misused or mislabled as a food, drug, or supplement.
Bodily Introduction of any kind into humans or animals is strictly forbidden by law.
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.
10 mg Lyophilized powder.
PLEASE READ OUR FAQ BEFORE YOU ORDER. CLICK HERE
THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This product is intended for in vitro laboratory research use only. All Information on this website is for educational purposes only.
This product should only be handled by licensed, qualified professionals.
This product is not a food, drug, or supplement and may not be misbranded, misused or mislabled as a food, drug, or supplement.
Bodily Introduction of any kind into humans or animals is strictly forbidden by law.
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is required.